Hydrocodone Polistirex and Chlorpheniramine Polistirex · HYDROCODONE BITARTRATE 10 mg/5mL; CHLORPHENIRAMINE MALEATE 8 mg/5mL · Suspension, Extended Release · Oral · Cranbury Pharmaceuticals, LLC
NDC 27808-0086-02 · 473 mL in 1 BOTTLE · ANDA · View full market →
Just 2 companies supply this market — thin enough that a single exit would be felt immediately. The price has jumped 80% in a year, to $0.6503 per mL — sharp rises like this often mean supply is already tightening. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.
Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Some pressure is visible, but not much — here’s everything the score found to count.
The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026
price up 30% YoY · sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
No FDA shortage reports for this drug or its presentations.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Bryant Ranch Prepack | HYDROCODONE BITARTRATE 10 mg/5mL; CHLORPHENIRAMINE MALEATE 8 mg/5mL | Aug 26, 2026 | Sep 3, 2026 |
| Cranbury Pharmaceuticals, LLC | HYDROCODONE BITARTRATE 10 mg/5mL; CHLORPHENIRAMINE MALEATE 8 mg/5mL | Aug 26, 2026 | Sep 2, 2026 |
| Bryant Ranch Prepack | HYDROCODONE BITARTRATE 8 mg/5mL; CHLORPHENIRAMINE MALEATE 10 mg/5mL | Jul 22, 2026 | Aug 22, 2026 |
| Cranbury Pharmaceuticals, LLC | HYDROCODONE BITARTRATE 8 mg/5mL; CHLORPHENIRAMINE MALEATE 10 mg/5mL | Jul 22, 2026 | Aug 19, 2026 |
| Bryant Ranch Prepack | CHLORPHENIRAMINE MALEATE 8 mg/5mL; HYDROCODONE BITARTRATE 10 mg/5mL | Jul 15, 2026 | Jul 18, 2026 |
| Cranbury Pharmaceuticals, LLC | CHLORPHENIRAMINE MALEATE 8 mg/5mL; HYDROCODONE BITARTRATE 10 mg/5mL | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Hydrocodone Polistirex and Chlorpheniramine Polistirex extended-release — NDC 27808-0086-02," retrieved September 3, 2026, https://drugdashboards.com/drug/27808008602.
Free to cite with attribution — see how the data is put together.